Last reviewed · How we verify
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study (Allo-IM)
The purpose of this study is to identifying the intramuscular dose equivalent to the 4mg intravenous dose and assess its safety and tolerability as a weekly injection.
Details
| Lead sponsor | University of Arizona |
|---|---|
| Phase | PHASE1 |
| Status | TERMINATED |
| Enrolment | 6 |
| Start date | Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Dec 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Alzheimer Dementia
Interventions
- Allopregnanolone
Countries
United States